Merit Medical Systems (MMSI) HR chief gets stock awards, surrenders shares for taxes

Rhea-AI Filing Summary

Merit Medical Systems’ chief human resources officer, Michel J. Voigt, reported equity awards and related tax withholding in company stock. On February 26, 2026, he received three stock awards totaling 31,101 shares of common stock at no purchase price, including restricted stock units and performance-based shares.

Footnotes state that two awards are restricted stock units vesting in scheduled installments, and one reflects earned performance stock units granted on February 28, 2023. Voigt then surrendered 6,698 shares back to the issuer at $78.02 per share to cover payroll and income taxes, with no open-market sale. Following these transactions, he directly held 46,127 common shares, plus additional non-qualified stock options and 15 shares held indirectly through a 401(k) plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Voigt Michel J.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF HUMAN RESOURCES OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value								15	I	By 401(k) Plan(1)
Common Stock, No Par Value	02/26/2026		A		7,690(2)	A	$0	29,414	D
Common Stock, No Par Value	02/26/2026		A		6,409(3)	A	$0	35,823	D
Common Stock, No Par Value	02/26/2026		A		17,002(4)	A	$0	52,825	D
Common Stock, No Par Value	02/26/2026		F		6,698(5)	D	$78.02	46,127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$56.25							03/19/2022(6)	03/19/2028	Common Stock	2,420		2,420	D
Non-qualified stock options (right to buy)	$65.03							02/28/2023(7)	02/28/2029	Common Stock	4,046		4,046	D
Non-qualified stock options (right to buy)	$70.58							02/28/2024(8)	02/28/2030	Common Stock	11,076		11,076	D

Explanation of Responses:

1. Represents plan holdings as of 02/26/2026.

2. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

3. Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

4. These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

5. The Reporting Person surrendered 6,698 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

6. Become exercisable in equal annual installments of 25% commencing on 03/19/2022.

7. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.

8. Become exercisable in equal annual installments of 25% commencing on 02/28/2024.

	/s/ Brian G. Lloyd, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MMSI executive Michel Voigt report?

Michel J. Voigt reported stock awards and related tax withholding in Merit Medical Systems shares. He received 31,101 common shares via equity awards and surrendered 6,698 shares back to the company to satisfy payroll and income tax obligations, with no open-market sale involved.

How many Merit Medical (MMSI) shares did Michel Voigt acquire?

On February 26, 2026, Michel J. Voigt acquired 31,101 Merit Medical common shares through equity awards at no purchase price. These included restricted stock units and performance-based shares, each representing the right to receive one share of common stock upon vesting over future years.

Why did Michel Voigt dispose of 6,698 MMSI shares?

Michel J. Voigt surrendered 6,698 Merit Medical shares to the issuer to cover payroll and income tax liabilities tied to his stock awards. A footnote clarifies these shares were not sold in the open market but used solely for tax withholding purposes with the company.

What is Michel Voigt’s Merit Medical stock ownership after these transactions?

After the reported transactions, Michel J. Voigt directly held 46,127 shares of Merit Medical common stock. He also had additional non-qualified stock options outstanding and 15 common shares held indirectly through a 401(k) plan, according to the Form 4 data and accompanying footnotes.

How do the RSU grants to MMSI’s CHRO vest over time?

The filing describes restricted stock units granted to Michel J. Voigt that vest in scheduled installments. One RSU grant vests in three equal annual installments, while another vests in two equal installments on the second and third anniversaries of the grant date, subject to continued service.

What are the performance stock units mentioned in the MMSI Form 4?

One line item reflects shares issued after the Compensation and Talent Development Committee determined conditions were met for performance stock units granted on February 28, 2023. These shares were delivered upon satisfaction of those performance criteria, increasing Michel J. Voigt’s common stock holdings.